<?xml version="1.0" encoding="UTF-8" ?><rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xml:lang="en">
<channel rdf:about="http://www.giiresearch.com/topics/PH08_en.shtml">
  <title>Market Research Reports for Generic Drugs</title>
  <link>http://www.giiresearch.com/topics/PH08_en.shtml</link>
  <description>Market Research Reports for Generic Drugs</description>
  <dc:publisher>Global Information, Inc.</dc:publisher>
  <dc:rights>(C) 2013 Global Information, Inc.</dc:rights>
  <dc:date>2013-06-18</dc:date>
  <sy:updatePeriod>daily</sy:updatePeriod>
  <items>
    <rdf:Seq>
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es234936-world-generic-market-report-2012.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/pmr237212-generic-innovative-drugs-market-central-europe.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd273182-pharmasphere-global-biosimilars-strategy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/cei121988-generic-biosimilar.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/lmer146105-thera-protein-bio.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/pmr179466-generic-drug-russia.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt204743-biosimilars-follow-on-biologics-world-market-2011.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl273168-branded-generics-strategies-tactics-winning-latin.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd267065-pharmaleaders-generic-manufacturers-benchmark.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd267066-pharmasphere-global-generics-strategy-key-drivers.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc268435-russia-generics-biosimilars.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl268895-biosimilars-emerging-markets.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi257409-generic-growth-strategies-market-driven-by.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/inde255553-global-biosimilars-market-products-applications.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt220569-generic-drugs-world-market-outlook-2011-2021.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs249890-opportunity-analysis-biosimilars-south-korea.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl250781-charting-biosimilar-biobetter-development-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc250554-generics-analysis-key-patent-case-reviews.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/hui254654-profound-research-investment-prospect-chinas.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc250571-eu-biosimilars-database.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mkl251357-generics-global-industry-guide.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc248094-intas-biosimilars-company-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/koan142228-biosimilars.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi246719-biosimilars-developed-countries-launch-biosimilar.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi246722-biobetters-key-markets-opportunities-biotechnology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc248088-zydus-cadila-biosimilars-company-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc248089-harvest-moon-pharmaceuticals-biosimilars-company.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc248092-dr-reddys-biosimilars-company-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc248093-celltrion-biosimilars-company-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc248095-sandoz-biosimilars-company-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc248096-teva-biosimilars-company-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc248091-biocon-biosimilars-company-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc248076-generics-us-regulatory-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc248090-lg-life-sciences-biosimilars-company-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi245748-generics-antivirals-market-2018-launch-generic.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi245749-biosimilars-emerging-economies-advanced.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es115822-inhala-nasal-spray.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rnc212646-cancer-generics-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/pmr251804-generic-innovative-drugs-market-poland-development.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc242224-biosimilars-global-markets.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi241634-generics-cardiovascular-diseases-market-2018-loss.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rb243910-generic-defense-strategies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc243929-biosimilars-global-regulatory-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi238357-pricing-reimbursement-generics-european-austerity.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi238361-growth-strategies-supergenerics-organizations.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/go240198-biosimilars.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl242956-branded-generics-south-east-asia-current-future.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl242958-generics-vehicle-improve-market-access.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt239211-pharma-leader-series-top-50-generic-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jph233565-biosimilars-current-situation-future-prospects.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rnc234009-global-biosimilars-market-forecast-2015.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi232659-global-biosimilar-market-2010-2014.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rnc231240-japan-generics-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl229466-gauging-biosimilar-effect-will-market-boom-or-bust.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es229669-global-biosimilars-return-optimism.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rb234135-generics-japan.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs227336-generic-pharmaceuticals-market-global-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs226614-analysis-european-biosimilars-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr227314-special-report-patterns-generic-erosion.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs228271-specialty-physicians-discuss-their-opinions-united.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es225456-generic-drugs-global-collaboration-opportunities.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr224115-will-big-pharma-find-success-generics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl222810-biosimilar-drugs-europe-threat-or-opportunity.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc229431-canada-generics-biosimilars-overview.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rnc223495-generic-drug-market-canada.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es220551-multi-therapy-drugs-opportunities-generics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/imarc219015-biosimilar-follow-on-biologics-market-report.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc229415-biosimilars-india-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl216737-biobetters-major-players-market-prospects-2nd.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc252980-biosimilars-china-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr214045-success-biobetters-young-biobetters-companies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc210427-generic-drugs-global-market-focus-on-europe.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc210428-generic-drugs-global-market-focus-on-americas.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc210430-generic-drugs-global-market-focus-on-asia.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr210203-biosimilar-opportunities-pipelines-companies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc210210-generic-drugs-global-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rnc207189-booming-generics-drug-market-india.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/imarc208490-us-biosimilar-follow-on-biologics-market-report.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es206607-hospital-injectable-drugs-future-prospects.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/eo206907-generic-drugs-consumer-health-global-overview-2011.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc206510-mexico-generics-biosimilars-overview.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc206530-turkey-generics-biosimilars-overview.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs194132-strategic-analysis-indian-biosimilar-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi196222-generic-growth-strategies-manufacturers-increase.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc195991-pharmaceutical-key-trends-2011-generics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi179441-biosimilar.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rnc179898-uk-generics-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs201028-japan-generics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs201030-south-korea-generics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs201032-australia-generics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rnc172036-japanese-generic.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rnc172281-us-generic-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc176920-pharmaceutical.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl214804-biosimilars-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl232502-biosimilars-regulatory-update-evolving-landscape.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es144366-global-biosimilar.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rnc143330-brazil-generics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr142939-biologics-biosimilars.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi146082-biotechnology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi146089-patent.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr142911-biologic-biosimi-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr142022-biologic-biosi-immu.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt144594-us-pharma.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr139297-generic-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc142033-generic.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr139301-biologic-biosimi-cns.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rb200322-growth-strategies-supergenerics-organizations.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es135779-global-generics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc144082-generics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/lmer134392-biosimi-be-sup-antib.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs134199-s-east-asia-phar-generic.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rb128556-future-generic-ind.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ur119189-biosimilars.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc118411-global-industry.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115277-pharmaceuticals.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115278-pharmaceuticals.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115279-pharmaceuticals.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115280-pharmaceuticals-china.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115281-pharmaceuticals-europe.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115282-pharmaceuticals-france.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115283-pharmaceuticals-germany.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115284-pharmaceuticals-italy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115285-pharmaceuticals-japan.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115286-pharmaceuticals.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115287-pharmaceuticals-spain.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115288-pharmaceuticals-uk.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc115289-pharmaceuticals-us.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es105626-injectable-generic.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt105869-us-pharma-mkt.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/pmr104642-generic-innov-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt105875-in-pharma-mkt.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es102251-biosimilars.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rf106283-euro-generic-pharma.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mama100546-biosimilars.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es98613-generic-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kl96359-us-biosimi-biologic.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ur83659-generic-pharma.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs91118-eu-generic-pharma.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr78010-mfg-biosimilars.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs74674-eu-biosimilar.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es69402-us-pharma.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es143205-cns-generic-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kl64387-biogenerics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kl64698-generic-drugs.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arr60362-indian-generics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es66417-drugs-australia.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rnc58475-drugs-brazil.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es76135-generic-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es62476-generic-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kl56590-drug-pricing.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ur57663-generic-pharma.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rb56302-biosimilars.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs53409-off-patent.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es53083-generic-drugs.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs51697-pharmaceuticals.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es51147-generic-drugs.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es49763-generic-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ur49703-competition.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs48391-generics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs45127-id-biogenerics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/go43862-biogenerics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es37826-drugs.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kl37211-generic-drugs.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rb37088-generics-companies.html" />
    </rdf:Seq>
  </items>
</channel>
<item rdf:about="http://www.giiresearch.com/report/es234936-world-generic-market-report-2012.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-06-07</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>World Generic Market Report 2013</title>
  <link>http://www.giiresearch.com/report/es234936-world-generic-market-report-2012.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/pmr237212-generic-innovative-drugs-market-central-europe.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-05-31</dc:date>
  <dc:creator>PMR</dc:creator>
  <title>Generic and Innovative Drugs Market in Central Europe 2013: Comparative Analysis, Reimbursement Policies and Development Forecasts for 2013-2015</title>
  <link>http://www.giiresearch.com/report/pmr237212-generic-innovative-drugs-market-central-europe.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd273182-pharmasphere-global-biosimilars-strategy.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-05-27</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013</title>
  <link>http://www.giiresearch.com/report/gd273182-pharmasphere-global-biosimilars-strategy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/cei121988-generic-biosimilar.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-05-13</dc:date>
  <dc:creator>Cutting Edge Information</dc:creator>
  <title>Post-Patent Generic and Biosimilar Defense Strategies: Harnessing Competitive Tactics to Mitigate Revenue Erosion</title>
  <link>http://www.giiresearch.com/report/cei121988-generic-biosimilar.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/lmer146105-thera-protein-bio.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>La Merie Publishing</dc:creator>
  <title>Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters &amp; Biosuperiors</title>
  <link>http://www.giiresearch.com/report/lmer146105-thera-protein-bio.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/pmr179466-generic-drug-russia.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>PMR</dc:creator>
  <title>Generic and innovative drugs market in CIS countries 2013 - Russia, Ukraine and Kazakhstan: Development forecasts for 2013-2015</title>
  <link>http://www.giiresearch.com/report/pmr179466-generic-drug-russia.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt204743-biosimilars-follow-on-biologics-world-market-2011.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Biosimilars And Follow-On Biologics: World Market 2013-2023</title>
  <link>http://www.giiresearch.com/report/kt204743-biosimilars-follow-on-biologics-world-market-2011.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl273168-branded-generics-strategies-tactics-winning-latin.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Branded Generics: Strategies and Tactics for Winning in Latin America</title>
  <link>http://www.giiresearch.com/report/dgpl273168-branded-generics-strategies-tactics-winning-latin.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd267065-pharmaleaders-generic-manufacturers-benchmark.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-03-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking &amp; Competitive Analysis of the Leading Generic Players in 2013</title>
  <link>http://www.giiresearch.com/report/gd267065-pharmaleaders-generic-manufacturers-benchmark.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd267066-pharmasphere-global-generics-strategy-key-drivers.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-03-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013</title>
  <link>http://www.giiresearch.com/report/gd267066-pharmasphere-global-generics-strategy-key-drivers.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc268435-russia-generics-biosimilars.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-03-01</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Russia Generics and Biosimilars</title>
  <link>http://www.giiresearch.com/report/dc268435-russia-generics-biosimilars.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl268895-biosimilars-emerging-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-03-01</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Biosimilars in Emerging Markets</title>
  <link>http://www.giiresearch.com/report/dgpl268895-biosimilars-emerging-markets.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi257409-generic-growth-strategies-market-driven-by.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-12-14</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&amp;D Productivity and Government Initiatives to Reduce Healthcare Costs</title>
  <link>http://www.giiresearch.com/report/gbi257409-generic-growth-strategies-market-driven-by.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/inde255553-global-biosimilars-market-products-applications.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-11-26</dc:date>
  <dc:creator>Industry Experts</dc:creator>
  <title>Global Biosimilars Market - Products, Applications and Regulations</title>
  <link>http://www.giiresearch.com/report/inde255553-global-biosimilars-market-products-applications.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt220569-generic-drugs-world-market-outlook-2011-2021.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-11-13</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Generic Drugs: World Market 2013-2023</title>
  <link>http://www.giiresearch.com/report/kt220569-generic-drugs-world-market-outlook-2011-2021.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs249890-opportunity-analysis-biosimilars-south-korea.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2012-09-05</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Opportunity Analysis for Biosimilars - South Korea</title>
  <link>http://www.giiresearch.com/report/fs249890-opportunity-analysis-biosimilars-south-korea.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl250781-charting-biosimilar-biobetter-development-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-09-01</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Charting the Biosimilar and Biobetter Development Pipeline</title>
  <link>http://www.giiresearch.com/report/dgpl250781-charting-biosimilar-biobetter-development-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc250554-generics-analysis-key-patent-case-reviews.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-08-17</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Generics Analysis: Key Patent Case Reviews</title>
  <link>http://www.giiresearch.com/report/dc250554-generics-analysis-key-patent-case-reviews.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/hui254654-profound-research-investment-prospect-chinas.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-08-16</dc:date>
  <dc:creator>Huidian Research (Beijing BeiFuYuan Information Consulting Co., Ltd)</dc:creator>
  <title>Profound Research and Investment Prospect of China's Generic Drug Market, 2012-2016</title>
  <link>http://www.giiresearch.com/report/hui254654-profound-research-investment-prospect-chinas.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc250571-eu-biosimilars-database.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-08-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>EU Biosimilars Database</title>
  <link>http://www.giiresearch.com/report/dc250571-eu-biosimilars-database.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mkl251357-generics-global-industry-guide.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-08-01</dc:date>
  <dc:creator>MarketLine</dc:creator>
  <title>Generics: Global Industry Guide</title>
  <link>http://www.giiresearch.com/report/mkl251357-generics-global-industry-guide.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc248094-intas-biosimilars-company-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-07-24</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Intas: Biosimilars Company Analysis</title>
  <link>http://www.giiresearch.com/report/dc248094-intas-biosimilars-company-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/koan142228-biosimilars.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-07-10</dc:date>
  <dc:creator>Koncept Analytics</dc:creator>
  <title>Global Biosimilars Market Report: 2012 Edition</title>
  <link>http://www.giiresearch.com/report/koan142228-biosimilars.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi246719-biosimilars-developed-countries-launch-biosimilar.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-07-10</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth</title>
  <link>http://www.giiresearch.com/report/gbi246719-biosimilars-developed-countries-launch-biosimilar.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi246722-biobetters-key-markets-opportunities-biotechnology.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-07-10</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings</title>
  <link>http://www.giiresearch.com/report/gbi246722-biobetters-key-markets-opportunities-biotechnology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc248088-zydus-cadila-biosimilars-company-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-07-06</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Zydus Cadila: Biosimilars Company Analysis</title>
  <link>http://www.giiresearch.com/report/dc248088-zydus-cadila-biosimilars-company-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc248089-harvest-moon-pharmaceuticals-biosimilars-company.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-07-06</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Harvest Moon Pharmaceuticals: Biosimilars Company Analysis</title>
  <link>http://www.giiresearch.com/report/dc248089-harvest-moon-pharmaceuticals-biosimilars-company.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc248092-dr-reddys-biosimilars-company-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-07-06</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Dr. Reddy's: Biosimilars Company Analysis</title>
  <link>http://www.giiresearch.com/report/dc248092-dr-reddys-biosimilars-company-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc248093-celltrion-biosimilars-company-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-07-06</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Celltrion: Biosimilars Company Analysis</title>
  <link>http://www.giiresearch.com/report/dc248093-celltrion-biosimilars-company-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc248095-sandoz-biosimilars-company-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-07-06</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Sandoz: Biosimilars Company Analysis</title>
  <link>http://www.giiresearch.com/report/dc248095-sandoz-biosimilars-company-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc248096-teva-biosimilars-company-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-07-06</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Teva: Biosimilars Company Analysis</title>
  <link>http://www.giiresearch.com/report/dc248096-teva-biosimilars-company-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc248091-biocon-biosimilars-company-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-07-05</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Biocon: Biosimilars Company Analysis</title>
  <link>http://www.giiresearch.com/report/dc248091-biocon-biosimilars-company-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc248076-generics-us-regulatory-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-06-26</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Generics: US Regulatory Update</title>
  <link>http://www.giiresearch.com/report/dc248076-generics-us-regulatory-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc248090-lg-life-sciences-biosimilars-company-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-06-26</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>LG Life Sciences: Biosimilars Company Analysis</title>
  <link>http://www.giiresearch.com/report/dc248090-lg-life-sciences-biosimilars-company-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi245748-generics-antivirals-market-2018-launch-generic.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2012-06-25</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth</title>
  <link>http://www.giiresearch.com/report/gbi245748-generics-antivirals-market-2018-launch-generic.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi245749-biosimilars-emerging-economies-advanced.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-06-25</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production</title>
  <link>http://www.giiresearch.com/report/gbi245749-biosimilars-emerging-economies-advanced.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es115822-inhala-nasal-spray.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-06-11</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Inhalation &amp; Nasal Spray Generic Drugs 2012</title>
  <link>http://www.giiresearch.com/report/es115822-inhala-nasal-spray.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rnc212646-cancer-generics-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-06-01</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Cancer Generics Market Analysis</title>
  <link>http://www.giiresearch.com/report/rnc212646-cancer-generics-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/pmr251804-generic-innovative-drugs-market-poland-development.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-05-31</dc:date>
  <dc:creator>PMR</dc:creator>
  <title>Generic and innovative drugs market in Poland 2012: Development forecasts for 2012-2014</title>
  <link>http://www.giiresearch.com/report/pmr251804-generic-innovative-drugs-market-poland-development.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc242224-biosimilars-global-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-05-24</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Biosimilars: Global Markets</title>
  <link>http://www.giiresearch.com/report/bc242224-biosimilars-global-markets.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi241634-generics-cardiovascular-diseases-market-2018-loss.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-05-18</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution</title>
  <link>http://www.giiresearch.com/report/gbi241634-generics-cardiovascular-diseases-market-2018-loss.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rb243910-generic-defense-strategies.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-05-09</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>Generic Defense Strategies</title>
  <link>http://www.giiresearch.com/report/rb243910-generic-defense-strategies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc243929-biosimilars-global-regulatory-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-05-02</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Biosimilars: Global Regulatory Update</title>
  <link>http://www.giiresearch.com/report/dc243929-biosimilars-global-regulatory-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi238357-pricing-reimbursement-generics-european-austerity.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Regulation</dc:subject>
  <dc:date>2012-04-20</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure</title>
  <link>http://www.giiresearch.com/report/gbi238357-pricing-reimbursement-generics-european-austerity.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi238361-growth-strategies-supergenerics-organizations.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-04-20</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Growth Strategies for Supergenerics Organizations - Opportunities in Addressing Unmet Medical Needs and Providing Cost-Effective Solutions for Product Development in Emerging Markets</title>
  <link>http://www.giiresearch.com/report/gbi238361-growth-strategies-supergenerics-organizations.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/go240198-biosimilars.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-04-01</dc:date>
  <dc:creator>Global Industry Analysts, Inc.</dc:creator>
  <title>Biosimilars</title>
  <link>http://www.giiresearch.com/report/go240198-biosimilars.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl242956-branded-generics-south-east-asia-current-future.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-04-01</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Branded Generics in South East Asia: Current and Future Opportunities</title>
  <link>http://www.giiresearch.com/report/dgpl242956-branded-generics-south-east-asia-current-future.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl242958-generics-vehicle-improve-market-access.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-04-01</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Generics as a Vehicle to Improve Market Access</title>
  <link>http://www.giiresearch.com/report/dgpl242958-generics-vehicle-improve-market-access.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt239211-pharma-leader-series-top-50-generic-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-03-26</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022</title>
  <link>http://www.giiresearch.com/report/kt239211-pharma-leader-series-top-50-generic-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jph233565-biosimilars-current-situation-future-prospects.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-03-09</dc:date>
  <dc:creator>Justpharmareports</dc:creator>
  <title>Biosimilars: Current Situation &amp; Future Prospects, Worldwide</title>
  <link>http://www.giiresearch.com/report/jph233565-biosimilars-current-situation-future-prospects.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rnc234009-global-biosimilars-market-forecast-2015.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-03-01</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Global Biosimilars Market Forecast to 2015</title>
  <link>http://www.giiresearch.com/report/rnc234009-global-biosimilars-market-forecast-2015.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi232659-global-biosimilar-market-2010-2014.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-02-10</dc:date>
  <dc:creator>Infiniti Research Limited  (Technavio)</dc:creator>
  <title>Global Biosimilar Market 2010-2014</title>
  <link>http://www.giiresearch.com/report/infi232659-global-biosimilar-market-2010-2014.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rnc231240-japan-generics-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-02-01</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Japan Generics Market Analysis</title>
  <link>http://www.giiresearch.com/report/rnc231240-japan-generics-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl229466-gauging-biosimilar-effect-will-market-boom-or-bust.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-01-23</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Gauging the Biosimilar Effect: will the market boom or bust?</title>
  <link>http://www.giiresearch.com/report/dgpl229466-gauging-biosimilar-effect-will-market-boom-or-bust.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es229669-global-biosimilars-return-optimism.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-01-23</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Global Biosimilars: A return to optimism?</title>
  <link>http://www.giiresearch.com/report/es229669-global-biosimilars-return-optimism.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rb234135-generics-japan.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-01-23</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>Generics in Japan</title>
  <link>http://www.giiresearch.com/report/rb234135-generics-japan.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs227336-generic-pharmaceuticals-market-global-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-12-23</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Generic Pharmaceuticals Market - A Global Analysis</title>
  <link>http://www.giiresearch.com/report/fs227336-generic-pharmaceuticals-market-global-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs226614-analysis-european-biosimilars-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2011-12-20</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Analysis of European Biosimilars Market</title>
  <link>http://www.giiresearch.com/report/fs226614-analysis-european-biosimilars-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr227314-special-report-patterns-generic-erosion.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-12-20</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Special Report: Patterns of Generic Erosion: An International Chartbook</title>
  <link>http://www.giiresearch.com/report/dr227314-special-report-patterns-generic-erosion.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs228271-specialty-physicians-discuss-their-opinions-united.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2011-12-08</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Specialty Physicians Discuss their Opinions of the United States Biosimilars Market</title>
  <link>http://www.giiresearch.com/report/fs228271-specialty-physicians-discuss-their-opinions-united.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es225456-generic-drugs-global-collaboration-opportunities.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-12-02</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Generic Drugs: Global collaboration opportunities</title>
  <link>http://www.giiresearch.com/report/es225456-generic-drugs-global-collaboration-opportunities.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr224115-will-big-pharma-find-success-generics.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-11-18</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Will Big Pharma Find Success in Generics?</title>
  <link>http://www.giiresearch.com/report/dr224115-will-big-pharma-find-success-generics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl222810-biosimilar-drugs-europe-threat-or-opportunity.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-11-08</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Biosimilar Drugs in Europe: threat or opportunity to innovation?</title>
  <link>http://www.giiresearch.com/report/dgpl222810-biosimilar-drugs-europe-threat-or-opportunity.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc229431-canada-generics-biosimilars-overview.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-11-03</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Canada: Generics and Biosimilars Overview</title>
  <link>http://www.giiresearch.com/report/dc229431-canada-generics-biosimilars-overview.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rnc223495-generic-drug-market-canada.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-11-01</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Generic Drug Market in Canada</title>
  <link>http://www.giiresearch.com/report/rnc223495-generic-drug-market-canada.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es220551-multi-therapy-drugs-opportunities-generics.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-10-25</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Multi-therapy Drugs: Opportunities for Generics &amp; Biosimilars</title>
  <link>http://www.giiresearch.com/report/es220551-multi-therapy-drugs-opportunities-generics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/imarc219015-biosimilar-follow-on-biologics-market-report.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-10-17</dc:date>
  <dc:creator>IMARC Group</dc:creator>
  <title>Biosimilar/Follow-on Biologics Market Report &amp; Forecast: A Focus on the US (2011-2020)</title>
  <link>http://www.giiresearch.com/report/imarc219015-biosimilar-follow-on-biologics-market-report.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc229415-biosimilars-india-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-10-14</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Biosimilars: India Update</title>
  <link>http://www.giiresearch.com/report/dc229415-biosimilars-india-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl216737-biobetters-major-players-market-prospects-2nd.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-09-30</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Biobetters: Major Players and Market Prospects (2nd edition)</title>
  <link>http://www.giiresearch.com/report/dgpl216737-biobetters-major-players-market-prospects-2nd.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc252980-biosimilars-china-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-09-22</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Biosimilars: China Update</title>
  <link>http://www.giiresearch.com/report/dc252980-biosimilars-china-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr214045-success-biobetters-young-biobetters-companies.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-09-16</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Success with Biobetters: Young Biobetters Companies and Pipelines</title>
  <link>http://www.giiresearch.com/report/dr214045-success-biobetters-young-biobetters-companies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc210427-generic-drugs-global-market-focus-on-europe.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-09-08</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Generic Drugs: The Global Market--Focus on Europe</title>
  <link>http://www.giiresearch.com/report/bc210427-generic-drugs-global-market-focus-on-europe.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc210428-generic-drugs-global-market-focus-on-americas.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-09-08</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Generic Drugs: The Global Market-Focus on the Americas</title>
  <link>http://www.giiresearch.com/report/bc210428-generic-drugs-global-market-focus-on-americas.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc210430-generic-drugs-global-market-focus-on-asia.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-09-08</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Generic Drugs: The Global Market--Focus on Asia</title>
  <link>http://www.giiresearch.com/report/bc210430-generic-drugs-global-market-focus-on-asia.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr210203-biosimilar-opportunities-pipelines-companies.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-09-02</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Biosimilar Opportunities: Pipelines and Companies</title>
  <link>http://www.giiresearch.com/report/dr210203-biosimilar-opportunities-pipelines-companies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc210210-generic-drugs-global-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-09-01</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Generic Drugs: The Global Market</title>
  <link>http://www.giiresearch.com/report/bc210210-generic-drugs-global-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rnc207189-booming-generics-drug-market-india.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-08-01</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Booming Generics Drug Market in India</title>
  <link>http://www.giiresearch.com/report/rnc207189-booming-generics-drug-market-india.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/imarc208490-us-biosimilar-follow-on-biologics-market-report.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-07-30</dc:date>
  <dc:creator>IMARC Group</dc:creator>
  <title>US Biosimilar &amp; Follow-On Biologics Market Report (2011-2020): Problems, Prospects &amp; Projections</title>
  <link>http://www.giiresearch.com/report/imarc208490-us-biosimilar-follow-on-biologics-market-report.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es206607-hospital-injectable-drugs-future-prospects.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-07-25</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Hospital Injectable Drugs: Future Prospects for Generics &amp; Biosimilars</title>
  <link>http://www.giiresearch.com/report/es206607-hospital-injectable-drugs-future-prospects.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/eo206907-generic-drugs-consumer-health-global-overview-2011.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>OTC Drug</dc:subject>
  <dc:date>2011-07-13</dc:date>
  <dc:creator>Euromonitor International</dc:creator>
  <title>Generic Drugs in Consumer Health Global Overview 2011</title>
  <link>http://www.giiresearch.com/report/eo206907-generic-drugs-consumer-health-global-overview-2011.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc206510-mexico-generics-biosimilars-overview.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-07-07</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Mexico: Generics and Biosimilars Overview</title>
  <link>http://www.giiresearch.com/report/dc206510-mexico-generics-biosimilars-overview.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc206530-turkey-generics-biosimilars-overview.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-06-29</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Turkey: Generics and Biosimilars Overview</title>
  <link>http://www.giiresearch.com/report/dc206530-turkey-generics-biosimilars-overview.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs194132-strategic-analysis-indian-biosimilar-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2011-05-10</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Strategic Analysis of Indian Biosimilar Market</title>
  <link>http://www.giiresearch.com/report/fs194132-strategic-analysis-indian-biosimilar-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi196222-generic-growth-strategies-manufacturers-increase.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-05-09</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues</title>
  <link>http://www.giiresearch.com/report/gbi196222-generic-growth-strategies-manufacturers-increase.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc195991-pharmaceutical-key-trends-2011-generics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-04-18</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions</title>
  <link>http://www.giiresearch.com/report/dc195991-pharmaceutical-key-trends-2011-generics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi179441-biosimilar.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-04-01</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment</title>
  <link>http://www.giiresearch.com/report/gbi179441-biosimilar.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rnc179898-uk-generics-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-04-01</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>UK Generics Market Analysis</title>
  <link>http://www.giiresearch.com/report/rnc179898-uk-generics-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs201028-japan-generics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-03-17</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Japan Generics Market</title>
  <link>http://www.giiresearch.com/report/fs201028-japan-generics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs201030-south-korea-generics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-03-11</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>South Korea Generics Market</title>
  <link>http://www.giiresearch.com/report/fs201030-south-korea-generics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs201032-australia-generics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-03-11</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Australia Generics Market</title>
  <link>http://www.giiresearch.com/report/fs201032-australia-generics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rnc172036-japanese-generic.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-03-01</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Japanese Generic Market Forecast to 2013</title>
  <link>http://www.giiresearch.com/report/rnc172036-japanese-generic.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rnc172281-us-generic-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-03-01</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Booming US Generic Drug Market</title>
  <link>http://www.giiresearch.com/report/rnc172281-us-generic-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc176920-pharmaceutical.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-02-23</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceutical Key Trends 2011 - Biosimilar Market Overview</title>
  <link>http://www.giiresearch.com/report/dc176920-pharmaceutical.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl214804-biosimilars-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-02-01</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Biosimilars Update</title>
  <link>http://www.giiresearch.com/report/dgpl214804-biosimilars-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl232502-biosimilars-regulatory-update-evolving-landscape.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-02-01</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Biosimilars Regulatory Update: an evolving landscape</title>
  <link>http://www.giiresearch.com/report/dgpl232502-biosimilars-regulatory-update-evolving-landscape.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es144366-global-biosimilar.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-01-17</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Global Biosimilars: Identifying 2nd Generation Opportunities</title>
  <link>http://www.giiresearch.com/report/es144366-global-biosimilar.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rnc143330-brazil-generics.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Regulation</dc:subject>
  <dc:date>2011-01-01</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Brazil Generics Market Forecast to 2012</title>
  <link>http://www.giiresearch.com/report/rnc143330-brazil-generics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr142939-biologics-biosimilars.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2010-12-22</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Biologics/Biosimilars Leaders: The State of Play in Two Key Industry Sectors</title>
  <link>http://www.giiresearch.com/report/dr142939-biologics-biosimilars.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi146082-biotechnology.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2010-12-22</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions</title>
  <link>http://www.giiresearch.com/report/gbi146082-biotechnology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi146089-patent.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2010-12-22</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets</title>
  <link>http://www.giiresearch.com/report/gbi146089-patent.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr142911-biologic-biosimi-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2010-12-17</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Biologics/Biosimilars in Oncology: Blockbusters, Biosimilars, and Targeted Small Molecules Compete to Meet Unmet Needs</title>
  <link>http://www.giiresearch.com/report/dr142911-biologic-biosimi-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr142022-biologic-biosi-immu.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2010-12-14</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Biologics/Biosimilars in Immune and Inflammatory Disease: Will Novel Biologics and Biosimilars Disrupt Competitive Markets?</title>
  <link>http://www.giiresearch.com/report/dr142022-biologic-biosi-immu.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt144594-us-pharma.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-12-03</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>US Pharmaceutical Market Outlook 2011-2021</title>
  <link>http://www.giiresearch.com/report/kt144594-us-pharma.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr139297-generic-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2010-12-02</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>The Irresistible Rise of Generic Drugs in Mature and Emerging Markets: Implications for the Pharmaceutical Industry</title>
  <link>http://www.giiresearch.com/report/dr139297-generic-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc142033-generic.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2010-11-30</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Generic Market Outlook: 2015</title>
  <link>http://www.giiresearch.com/report/dc142033-generic.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr139301-biologic-biosimi-cns.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Neurodegenerative Disease</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2010-11-29</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Biologics/Biosimilars in CNS: Few Challengers to Small-Molecule Market Leaders</title>
  <link>http://www.giiresearch.com/report/dr139301-biologic-biosimi-cns.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rb200322-growth-strategies-supergenerics-organizations.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2010-11-29</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>Growth Strategies for Supergenerics Organizations</title>
  <link>http://www.giiresearch.com/report/rb200322-growth-strategies-supergenerics-organizations.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es135779-global-generics.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2010-10-21</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Partnering in the Global Generics Industry 2010: A guide to companies</title>
  <link>http://www.giiresearch.com/report/es135779-global-generics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc144082-generics.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2010-10-15</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Generics Market Outlook: 2015</title>
  <link>http://www.giiresearch.com/report/dc144082-generics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/lmer134392-biosimi-be-sup-antib.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2010-10-01</dc:date>
  <dc:creator>La Merie Publishing</dc:creator>
  <title>Competitor Analysis: Biosimilar and Biobetter/Biosuperior Antibodies</title>
  <link>http://www.giiresearch.com/report/lmer134392-biosimi-be-sup-antib.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs134199-s-east-asia-phar-generic.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2010-09-23</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Southeast Asian Pharmaceuticals Industry: Generic Drug Market</title>
  <link>http://www.giiresearch.com/report/fs134199-s-east-asia-phar-generic.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rb128556-future-generic-ind.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2010-08-30</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>The Future of the Generics Industry: Opportunities, threats and key trends</title>
  <link>http://www.giiresearch.com/report/rb128556-future-generic-ind.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ur119189-biosimilars.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2010-03-25</dc:date>
  <dc:creator>Urch Publishing, Ltd.</dc:creator>
  <title>Biosimilars: A Growing Market An overview of developments, companies &amp; commercial opportunities</title>
  <link>http://www.giiresearch.com/report/ur119189-biosimilars.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc118411-global-industry.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2010-02-25</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: Global Industry Overview</title>
  <link>http://www.giiresearch.com/report/dc118411-global-industry.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115277-pharmaceuticals.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: Asia-Pacific Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115277-pharmaceuticals.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115278-pharmaceuticals.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: Belgium Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115278-pharmaceuticals.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115279-pharmaceuticals.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: Canada Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115279-pharmaceuticals.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115280-pharmaceuticals-china.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: China Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115280-pharmaceuticals-china.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115281-pharmaceuticals-europe.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: Europe Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115281-pharmaceuticals-europe.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115282-pharmaceuticals-france.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: France Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115282-pharmaceuticals-france.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115283-pharmaceuticals-germany.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: Germany Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115283-pharmaceuticals-germany.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115284-pharmaceuticals-italy.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: Italy Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115284-pharmaceuticals-italy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115285-pharmaceuticals-japan.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: Japan Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115285-pharmaceuticals-japan.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115286-pharmaceuticals.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: Netherlands Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115286-pharmaceuticals.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115287-pharmaceuticals-spain.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: Spain Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115287-pharmaceuticals-spain.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115288-pharmaceuticals-uk.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: United Kingdom Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115288-pharmaceuticals-uk.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc115289-pharmaceuticals-us.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2010-02-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pharmaceuticals: United States Industry Guide</title>
  <link>http://www.giiresearch.com/report/dc115289-pharmaceuticals-us.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es105626-injectable-generic.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2009-12-16</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Injectable Generic Drugs: Prospects &amp; Opportunities to 2013</title>
  <link>http://www.giiresearch.com/report/es105626-injectable-generic.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt105869-us-pharma-mkt.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2009-11-23</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>The US Pharmaceutical Market 2009-2024</title>
  <link>http://www.giiresearch.com/report/kt105869-us-pharma-mkt.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/pmr104642-generic-innov-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2009-11-20</dc:date>
  <dc:creator>PMR</dc:creator>
  <title>Generic and innovative drugs markets in Central and Eastern Europe 2009</title>
  <link>http://www.giiresearch.com/report/pmr104642-generic-innov-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt105875-in-pharma-mkt.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>OTC Drug</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2009-11-11</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Indian Pharmaceutical Market Outlook 2009-2024</title>
  <link>http://www.giiresearch.com/report/kt105875-in-pharma-mkt.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es102251-biosimilars.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2009-10-15</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Biosimilars: Beyond the first product wave</title>
  <link>http://www.giiresearch.com/report/es102251-biosimilars.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rf106283-euro-generic-pharma.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2009-10-01</dc:date>
  <dc:creator>Research Facts Ltd.</dc:creator>
  <title>The Top 60 European Manufacturers Of Generic Pharmaceuticals</title>
  <link>http://www.giiresearch.com/report/rf106283-euro-generic-pharma.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mama100546-biosimilars.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2009-09-24</dc:date>
  <dc:creator>Markets and Markets</dc:creator>
  <title>Biosimilars (2009 - 2014)</title>
  <link>http://www.giiresearch.com/report/mama100546-biosimilars.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es98613-generic-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2009-08-21</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Emerging Opportunities in Controlled-Release Generic Drugs</title>
  <link>http://www.giiresearch.com/report/es98613-generic-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kl96359-us-biosimi-biologic.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2009-08-01</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>The World Market for Biosimilars and the Potential for US Follow-on Biologics</title>
  <link>http://www.giiresearch.com/report/kl96359-us-biosimi-biologic.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ur83659-generic-pharma.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2009-03-17</dc:date>
  <dc:creator>Urch Publishing, Ltd.</dc:creator>
  <title>How to Forecast Generic Pharmaceutical Prices</title>
  <link>http://www.giiresearch.com/report/ur83659-generic-pharma.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs91118-eu-generic-pharma.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2008-12-31</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Emerging Generic Pharmaceuticals Markets in Europe</title>
  <link>http://www.giiresearch.com/report/fs91118-eu-generic-pharma.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr78010-mfg-biosimilars.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2008-11-25</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Meeting the Challenges of Manufacturing Biosimilars</title>
  <link>http://www.giiresearch.com/report/dr78010-mfg-biosimilars.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs74674-eu-biosimilar.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2008-09-24</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Biosimilars Market Outlook</title>
  <link>http://www.giiresearch.com/report/fs74674-eu-biosimilar.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es69402-us-pharma.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2008-06-18</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>All Change in the US Pharma Market?</title>
  <link>http://www.giiresearch.com/report/es69402-us-pharma.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es143205-cns-generic-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Neurodegenerative Disease</dc:subject>
  <dc:date>2008-04-25</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>CNS Generic Drugs: Prospects and Opportunities to 2012</title>
  <link>http://www.giiresearch.com/report/es143205-cns-generic-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kl64387-biogenerics.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2008-04-01</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>Biogenerics: The World Market for Biosimilars</title>
  <link>http://www.giiresearch.com/report/kl64387-biogenerics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kl64698-generic-drugs.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2008-04-01</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>World Market for Prescription Generic Drugs, 6th Edition</title>
  <link>http://www.giiresearch.com/report/kl64698-generic-drugs.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arr60362-indian-generics.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2008-03-14</dc:date>
  <dc:creator>Arrowhead Publishers</dc:creator>
  <title>Indian Generics, 2008-2012 The Growing Threat to Westernised Markets</title>
  <link>http://www.giiresearch.com/report/arr60362-indian-generics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es66417-drugs-australia.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2008-03-06</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Opportunities and Challenges for Generic Drugs in Australia</title>
  <link>http://www.giiresearch.com/report/es66417-drugs-australia.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rnc58475-drugs-brazil.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2007-12-31</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Generic Drugs Market in Brazil (2007-2011)</title>
  <link>http://www.giiresearch.com/report/rnc58475-drugs-brazil.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es76135-generic-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2007-12-31</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Cardiovascular Generic Drugs: Prospects and Opportunities to 2012</title>
  <link>http://www.giiresearch.com/report/es76135-generic-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es62476-generic-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2007-12-05</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Emerging Generic Drug Markets in Europe</title>
  <link>http://www.giiresearch.com/report/es62476-generic-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kl56590-drug-pricing.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2007-10-01</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>A Guide to Drug Pricing and Reimbursement</title>
  <link>http://www.giiresearch.com/report/kl56590-drug-pricing.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ur57663-generic-pharma.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2007-10-01</dc:date>
  <dc:creator>Urch Publishing, Ltd.</dc:creator>
  <title>Consolidation in the Generic Pharmaceutical Industry: An evolving landscape</title>
  <link>http://www.giiresearch.com/report/ur57663-generic-pharma.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rb56302-biosimilars.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2007-08-01</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>The Future of Biosimilars: Key opportunities &amp; emerging therapies</title>
  <link>http://www.giiresearch.com/report/rb56302-biosimilars.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs53409-off-patent.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2007-06-30</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Blockbusters Going Off-patent: Opportunities for Generics Manufacturers in Europe</title>
  <link>http://www.giiresearch.com/report/fs53409-off-patent.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es53083-generic-drugs.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2007-06-26</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Opportunities and Challenges for Generic Drugs in the UK</title>
  <link>http://www.giiresearch.com/report/es53083-generic-drugs.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs51697-pharmaceuticals.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2007-04-30</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. Generic Pharmaceuticals Outlook</title>
  <link>http://www.giiresearch.com/report/fs51697-pharmaceuticals.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es51147-generic-drugs.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2007-04-12</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil</title>
  <link>http://www.giiresearch.com/report/es51147-generic-drugs.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es49763-generic-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2007-02-23</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Emerging Generic Drug Companies Worldwide 2007</title>
  <link>http://www.giiresearch.com/report/es49763-generic-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ur49703-competition.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2007-02-20</dc:date>
  <dc:creator>Urch Publishing, Ltd.</dc:creator>
  <title>Generic Competition 2007 to 2011: The impact of patent expiries on sales of major drugs</title>
  <link>http://www.giiresearch.com/report/ur49703-competition.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs48391-generics.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2006-12-28</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Pricing and Reimbursement Issues for Generics &amp; Biosimilars Markets in Europe</title>
  <link>http://www.giiresearch.com/report/fs48391-generics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs45127-id-biogenerics.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2006-08-04</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Indian Biogenerics Markets</title>
  <link>http://www.giiresearch.com/report/fs45127-id-biogenerics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/go43862-biogenerics.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2006-07-30</dc:date>
  <dc:creator>Global Industry Analysts, Inc.</dc:creator>
  <title>Biogenerics</title>
  <link>http://www.giiresearch.com/report/go43862-biogenerics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es37826-drugs.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2006-04-21</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>The Latin American Market for Generic Drugs</title>
  <link>http://www.giiresearch.com/report/es37826-drugs.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kl37211-generic-drugs.html">
  <dc:language>en</dc:language>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2006-04-03</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>The World Market for Prescription Generic Drugs, 5th Edition</title>
  <link>http://www.giiresearch.com/report/kl37211-generic-drugs.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rb37088-generics-companies.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2006-03-23</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>The Top 10 Generics Companies: Strategic insight, growth opportunities and competitive dynamics in the US and Europe</title>
  <link>http://www.giiresearch.com/report/rb37088-generics-companies.html</link>
  <description></description>
</item>
</rdf:RDF>